Open AccessDays of Prophylactic Filgrastim Use to Reduce Febrile Neutropenia in Patients
Author(s) -
Shane Scott,
Bradley S. Stolshek,
Moshe Fridman,
David J. Delgado,
Brian K. Link,
Elizabeth A. Chrischilles
Publication year - 2003
Publication title -
journal of managed care pharmacy
Language(s) - English
Resource type - Journals
eISSN - 1944-706X
pISSN - 1083-4087
DOI - 10.18553/jmcp.2003.9.s2.15
Subject(s) - medicine , filgrastim , febrile neutropenia , neutropenia , vincristine , chemotherapy , prednisone , surgery , chop , incidence (geometry) , granulocyte colony stimulating factor , cyclophosphamide , physics , optics
Filgrastim prophylaxis lessens the occurrence of febrile neutropenia in patients with non-Hodgkin.s lymphoma (NHL) treated with chemotherapy, but differences in days of therapy and mode (primary or secondary) of prophylaxis may affect clinical outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom